Erste Group Upgrades Amgen (AMGN) to Buy

Erste Group analyst Hans Engel upgraded Amgen (NASDAQ: AMGN) from Hold to Buy.

The analyst comments "Amgen has a higher operating margin and a higher return on equity than the sector average. Sales and operating income will continue to rise in the coming quarters. The stock is attractively valued according to the P/E ratio. It also has a comparatively high dividend yield."

For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.

Shares of Amgen closed at $289.02 yesterday.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders
• Shoe Station Group (SHOE) PT Lowered to $15 at Williams Trading